Atlas Arteria (ALX) Stock Statistics & Valuation Metrics

Atlas Arteria has a market cap or net worth of AU$7.07B. The enterprise value is AU$8.85B.

Atlas Arteria has 1.45B shares outstanding. The number of shares has decreased by -2.65% in one year.

Atlas Arteria’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Atlas Arteria is ―. Atlas Arteria’s PEG ratio is ―.

In the last 12 months, Atlas Arteria had revenue of AU$140.10M and earned AU$234.00M in profits. Earnings per share was AU$0.16.

In the last 12 months, operating cash flow was AU$735.70M and capital expenditures -AU$800.00K, giving a free cash flow of AU$734.90M billion.

Atlas Arteria pays an annual dividend of AU$0.20, resulting in a dividend yield of 8.59%

Atlas Arteria upcoming earnings date is Aug 27, 2025, TBA.

Atlas Arteria as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Atlas Arteria has paid AU$3.30M in taxes.

Atlas Arteria EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Atlas Arteria has AU$229.50M in cash and marketable securities with AU$1.67B in debt, giving a net cash position of AU$1.44B billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Atlas Arteria is AU$5.39, which is 11.43% higher than the current price. The consensus rating is Moderate Buy